Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA.
Arizona Department of Public Health, Phoenix, AZ.
JCO Oncol Pract. 2022 Oct;18(10):e1704-e1715. doi: 10.1200/OP.22.00078. Epub 2022 Aug 8.
Since 2016, the American College of Surgeons' Commission on Cancer (CoC) has required routine distress screening (DS) of cancer survivors treated in their accredited facilities to facilitate early identification of survivors with psychosocial concerns. Lung and ovarian cancer survivors have relatively low 5-year survival rates and may experience high levels of distress. We examined the extent to which ovarian and lung cancer survivors received CoC-mandated DS and whether DS disparities exist on the basis of diagnosis, sociodemographic factors, or facility geography (urban/rural).
This study included a quantitative review of DS documentation and follow-up services provided using existing electronic health records (EHRs). We worked with 21 CoC-accredited facilities across the United States and examined EHRs of 2,258 survivors from these facilities (1,618 lung cancer survivors and 640 ovarian cancer survivors) diagnosed in 2016 or 2017.
Documentation of DS was found in half (54.8%) of the EHRs reviewed. Disparities existed across race/ethnicity, cancer type and stage, and facility characteristics. Hispanic/Latino and Asian/Pacific Islander survivors were screened at lower percentages than other survivors. Patients with ovarian cancer, those diagnosed at earlier stages, and survivors in urban facilities had relatively low percentages of DS. Non-Hispanic Black survivors were more likely than non-Hispanic White survivors to decline further psychosocial services.
Despite the mandate for routine DS in CoC-accredited oncology programs, gaps remain in how many and which survivors are screened for distress. Improvements in DS processes to enhance access to DS and appropriate psychosocial care could benefit cancer survivors. Collaboration with CoC during this study led to improvement of their processes for collecting DS data for measuring standard adherence.
自 2016 年以来,美国外科医师学会癌症委员会(CoC)要求在其认可的设施中对接受治疗的癌症幸存者进行常规痛苦筛查(DS),以方便早期发现有心理社会问题的幸存者。肺癌和卵巢癌幸存者的 5 年生存率相对较低,可能经历较高水平的痛苦。我们研究了卵巢癌和肺癌幸存者接受 CoC 规定的 DS 的程度,以及根据诊断、社会人口统计学因素或设施地理位置(城市/农村)是否存在 DS 差异。
本研究包括对使用现有电子健康记录(EHR)提供的 DS 文档和随访服务进行定量审查。我们与美国 21 家 CoC 认可的机构合作,检查了这些机构的 2258 名幸存者的 EHR(1618 名肺癌幸存者和 640 名卵巢癌幸存者),这些幸存者于 2016 年或 2017 年被诊断为癌症。
在审查的 EHR 中,有一半(54.8%)记录了 DS。在种族/族裔、癌症类型和分期以及设施特征方面存在差异。西班牙裔/拉丁裔和亚裔/太平洋岛裔幸存者的筛查率较低。卵巢癌患者、早期诊断患者和城市设施中的幸存者的 DS 筛查率相对较低。非西班牙裔黑人幸存者比非西班牙裔白人幸存者更有可能拒绝进一步的心理社会服务。
尽管 CoC 认可的肿瘤学项目中规定了常规 DS,但仍存在有多少幸存者和哪些幸存者接受痛苦筛查的问题。改进 DS 流程以增加对 DS 和适当心理社会护理的获取,可以使癌症幸存者受益。在这项研究中与 CoC 的合作导致了他们改进了收集 DS 数据以衡量标准依从性的流程。